Frontotemporal dementia patients with extrapyramidal symptoms have brainstem atrophy and reduced metabolism in certain areas of the brain significantly more often than patients without extrapyramidal ...
EPSs are serious, debilitating and stigmatizing adverse effects that frequently require additional pharmacotherapy. 3 The two types of EPSs are as follows: early acute EPS, which most often develops ...
Journal of Avian Medicine and Surgery, Vol. 22, No. 3 (Sep., 2008), pp. 234-239 (6 pages) A diagnosis of adverse extrapyramidal symptoms (EPS) was reached in a 14-year-old female blue and gold macaw ...
To the Editor: In the Current Concepts in Therapy, "Complications from Psychotherapeutic Drugs. I.," which appeared in the February 9 issue of the Journal, reference was made to the treatment tretment ...
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the journal's ...
The approval of Osmolex ER was based on bioavailability studies comparing Osmolex ER to immediate-release amantadine. Osmotica announced that the Food and Drug Administration (FDA) has approved ...
The diagnosis of VV1 sporadic Creutzfeldt–Jakob disease (sCJD) is extremely difficult, as this very rare subtype of sCJD shares many clinical characteristics with variant CJD (vCJD). Between 1993 and ...
Credit: Getty Images. Extrapyramidal symptoms that developed in patients with schizophrenia after initiation of treatment with atypical antipsychotic agents were associated with increased healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback